Nephros (NEPH) Change in Cash (2010 - 2026)
Nephros (NEPH) posted quarterly Change in Cash of -$1.4 million for Q1 2026, down 530.53% year-over-year from $321000.0 in Q1 2025, and down 703.49% quarter-over-quarter from $229000.0 in Q4 2025.
Nephros (NEPH) Change in Cash (2010 - 2026) Analysis & Trends
Nephros' Change in Cash history runs 17 years deep, the most recent figure standing at -$1.4 million for Q1 2026.
- In Q1 2026, Change in Cash fell 530.53% year-over-year to -$1.4 million; the TTM figure through Mar 2026 stood at -$63000.0 (down 114.06% YoY), while the FY2025 annual figure was $1.6 million, up 399.82% from the prior year.
- Change in Cash for Q1 2026 stood at -$1.4 million, down from $229000.0 in the prior quarter.
- The five-year high for Change in Cash was $1.3 million in Q4 2024, with the low at -$1.6 million in Q1 2022.
- The 5-year median for Change in Cash is -$239000.0 (2022), against an average of -$173823.5.
- The sharpest annual moves came in 2022 and 2024: Change in Cash slumped 1704.65% in 2022, then jumped 513.65% in 2024.
- Nephros' Change in Cash stood at -$306000.0 in 2022, then slipped by 2.94% to -$315000.0 in 2023, then surged by 513.65% to $1.3 million in 2024, then plunged by 82.43% to $229000.0 in 2025, then slumped by 703.49% to -$1.4 million in 2026.
- Business Quant data shows NEPH's Change in Cash at -$1.4 million in Q1 2026, $229000.0 in Q4 2025, and $97000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 753.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -152.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -223.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -191.28 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 91.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -85.60 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -157.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 14.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 137.00 Mn |
| 10 | Nephros | 45.71 Mn | 41.01 Mn | 4.03 Mn | 679,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 679,000.00 |
| Mar 31, 2026 | -1.38 Mn |
| Dec 31, 2025 | 229,000.00 |
| Sep 30, 2025 | 97,000.00 |
| Jun 30, 2025 | 993,000.00 |
| Mar 31, 2025 | 321,000.00 |
| Dec 31, 2024 | 1.30 Mn |
| Sep 30, 2024 | -623,000.00 |
| Jun 30, 2024 | -553,000.00 |
| Mar 31, 2024 | -674,000.00 |
| Dec 31, 2023 | -315,000.00 |
| Sep 30, 2023 | 562,000.00 |
| Jun 30, 2023 | 224,000.00 |
| Mar 31, 2023 | 202,000.00 |
| Dec 31, 2022 | -306,000.00 |
| Sep 30, 2022 | -239,000.00 |
| Jun 30, 2022 | -1.24 Mn |
| Mar 31, 2022 | -1.55 Mn |
| Dec 31, 2021 | -377,000.00 |
| Sep 30, 2021 | -928,000.00 |